Connect with us

Technology

Sorcero CEO Dipanwita Das Among Only 3 Founders in Life Sciences AI Recognized on 2026 100 Women in AI

Published

on

Das joins list with founders and innovators from the world’s top global AI companies, including Anthropic, OpenAI, NVIDIA, AMD, Microsoft, and Google

WASHINGTON, June 4, 2026 /PRNewswire/ — Sorcero, the AI-powered intelligence platform for life sciences, today announced that CEO and Co-founder Dipanwita Das was named to the 2026 100 Women in AI list. Das is one of only three female founders on the list recognized for shaping how AI is built, adopted, and understood in life sciences. She joins innovators at many of the world’s other top global AI companies, including Anthropic, OpenAI, NVIDIA, AMD, Microsoft, and Google.

Few applications of AI carry higher stakes and more promise than solving one of healthcare’s biggest challenges in getting the right therapies to the right patients at the right time. Sorcero is among the innovators helping improve patient outcomes globally. Its medically-tuned, agentic AI platform powers 40% of the top 30 global pharma companies, turning fragmented scientific data into actionable insight and evidence. The platform delivers 96.1% clinical accuracy – exceeding the FDA regulatory threshold – and cuts scientific data analysis time by over 72%, helping medical, safety, scientific communications, access, and commercial teams get evidence-backed therapies to patients faster.

“I’m honored to be named alongside an impressive list of women who have built many of the key foundational models, companies, and research shaping the future of AI, and grateful to the entire Sorcero team whose work made this possible,” said Das. “The major therapies of the next decade – more complex precision medicines and specialty drugs – will depend on how quickly scientific evidence reaches the researchers, clinicians, access, and safety teams who act on it. Publishing clinical trial results months sooner means less time a patient waits for a treatment that could change their life. When we strengthen how therapies are monitored after they reach the market, that’s safety patients can rely on. AI can do this, but only when it’s built for medicine, grounded in scientific evidence, and held to the regulatory rigor life sciences demands.”

The recognition follows a year of industry validations for Sorcero. In 2025, the company closed a $42.5M Series B led by NewSpring Capital, was recognized as Google Cloud’s Partner of the Year for Healthcare & Life Sciences, ranked 684 on the Inc. 5000 in its first year of inclusion, and was named one of America’s Most Innovative Companies by Fortune and one of the World’s Most Innovative Companies by Fast Company.

The 100 Women in AI list is produced annually by Flybridge and XFactor Ventures. Honorees are evaluated across six dimensions, including seniority, accomplishments, pedigree, impact, influence, and innovation, with scoring weighted toward real-world impact and how honorees have shaped the way AI is built and adopted. This year’s list drew more than 1,000 nominations from across the global innovation ecosystem, with honorees celebrated at a ceremony event in New York City.

View Das’ full honoree profile at 100womeninai.com/dipanwita-das. To see the complete 2026 honoree list, visit 100womeninai.com/full-list-2026.

About Sorcero
Sorcero is an AI and data intelligence platform that helps Medical Affairs, Scientific Communications, and Safety teams accelerate patient access to breakthrough therapies. Our medically-tuned AI is 96.1% accurate and cuts scientific data analysis time by over 72%, turning complex data into actionable insights in minutes. By streamlining evidence generation, Sorcero empowers experts to overcome market blockers and deliver life-changing treatments to those who need them most.

Headquartered in Washington, DC, Sorcero has earned over three dozen awards, including Google’s Partner of the Year for Healthcare & Life Sciences, America’s Most Innovative Companies by Fortune, Fast Company’s #1 most innovative company under 200 employees, and Inc. 5000 as one of the fastest-growing private companies. Learn more at: www.sorcero.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sorcero-ceo-dipanwita-das-among-only-3-founders-in-life-sciences-ai-recognized-on-2026-100-women-in-ai-302791915.html

SOURCE Sorcero

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Jen Aleman Hutter Named Chief Operating Officer of Physical Systems, Inc., the Parent Company of Click Bond, Inc.

Published

on

By

CARSON CITY, Nev., June 4, 2026 /PRNewswire/ — Click Bond, Inc. is excited to announce that Jen Aleman Hutter has accepted the role of Chief Operating Officer for Physical Systems, Inc. (PSI), the parent company of Click Bond, Inc. In this new role, Hutter will oversee the day-to-day operations across PSI’s growing portfolio, support the integration of acquired businesses, and lead shareholder relations, all while bringing a disciplined, people-centered approach to a pivotal period of expansion for the company.

Founded in 1967 by the Hutter family, PSI has operated on a consolidated basis with Click Bond, its wholly owned subsidiary, for nearly 40 years; both PSI and Click Bond have remained family-owned and operated. As PSI looked to broaden its investment scope and evaluate business opportunities both within and alongside Click Bond, the company’s Board of Directors recognized a need to evolve and strengthen its operating capabilities. Appointing Mrs. Hutter as COO reflects that evolution.

“Click Bond was built by my in-laws, Charlie and Collie Hutter, in the spirit of curiosity, innovation, and human-centered excellence,” said Mrs. Hutter. “It is an honor for me to serve in this role as COO of PSI as we expand the footprint of this proud legacy.”

Hutter brings more than two decades of experience in investment banking, entrepreneurship, and operational leadership to her new role. She began her career in public debt, private equity, and capital raising at Donaldson, Lufkin & Jenrette and Credit Suisse. Later, she cofounded KAP Group, a consulting firm that advised emerging private equity funds and platforms on institutional capital positioning — work guided by the principle “make it easy to invest with you,” a philosophy that continues to guide her approach to value creation.

She holds a Bachelor of Business Administration, magna cum laude, from Southern Methodist University, and a Master of Business Administration from Harvard Business School, where she remains active in alumni fundraising and applicant interviews. She has served on five nonprofit boards, including The Center Foundation, Sierra Nevada College, and Communities in Schools Nevada. She also currently serves as a Board Director for Sterling Realty Organization, a fourth-generation family business managing $1 billion in real estate assets.

Hutter’s involvement with PSI is expected to have direct benefits for Click Bond, providing even better support, shared resources, and a stronger foundation from which to grow.

“I was thrilled and honored when Jen, considering her next career options, expressed an interest in helping the family in a formal way; in truth, she has been doing so for 20 years!,” said Karl Hutter, CEO of Physical Systems and Click Bond as well as Mrs. Hutter’s husband. “Her deep familiarity with our family and alignment with our values and culture, combined with her extensive relevant experience beyond our walls, makes Jen a uniquely qualified leader in this role. As PSI’s next chapter takes shape, I am confident that Jen will bring strong process, incisive analysis, true heart, and bold imagination to building a bright and inspiring future for our family enterprise.”

Brandon Perlich, Click Bond’s President and Chief Financial Officer of Physical Systems, said, “I’m truly excited to welcome Jen Hutter as PSI’s COO. She brings a powerful combination of experience, judgment, and business insight that will help shape a bright future and elevate our organization. I look forward to partnering with her as we drive the next phase of growth together.”

Hutter’s leadership is further informed by her work as the founder of Girl, Slow Down, a movement dedicated to helping high-achieving women and girls redefine success through rest, intentionality, and presence. She strives to blend operational excellence with a deep commitment to compassionate leadership and sustainable performance, building enduring value while fostering cultures where people can thrive.

“I am dedicated to creating lasting value for our employees, our customers, and our shareholders, by showing up as a rested, present, and strategic thinker and leader,” she said.

About Click Bond
Click Bond, Inc. is a global leader in aerospace assembly technology and the pioneer of adhesive-bonded fastening for aerospace. The company creates innovative solutions, delivered through world-class manufacturing and customer support. Founded in 1987, Click Bond, Inc. is headquartered in Carson City, NV, with an additional manufacturing facility in Watertown, CT. For more information about Click Bond, visit www.clickbond.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/jen-aleman-hutter-named-chief-operating-officer-of-physical-systems-inc-the-parent-company-of-click-bond-inc-302792138.html

SOURCE Click Bond, Inc.

Continue Reading

Technology

701x Closes Oversubscribed Series B and Launches Global Expansion

Published

on

By

Community-funded round backed by North Dakotans and Minnesotans, along with rancher-users across the country marks a defining chapter for the only technology ecosystem built exclusively for the beef cattle industry.

FARGO, N.D., June 4, 2026 /PRNewswire/ — 701x, the Fargo, North Dakota-based agricultural technology company bringing connected intelligence to the beef cattle industry, today announced the close of an oversubscribed $10M Series B funding round. Marking six years in business with strong adoption across the United States, the company simultaneously announced it has hit profitability, added world-class talent, and is accelerating a major global expansion.

Unlike typical venture-backed technology companies, 701x’s Series B was raised entirely from individuals who believe in the company’s mission: local North Dakotans and Minnesotans extending to the greater Minneapolis area, and rancher-users from across the country who have experienced the 701x platform firsthand. No venture capital or institutional money was involved.

The Only Ecosystem Built for Beef Cattle

In six years, 701x has built what no other company has: a true, connected ecosystem of the most important technology tools focused exclusively on beef cattle. The 701x platform spans on-ranch software, breed association software, smart wearables, DNA solutions, and a growing accessory product line — all designed to work together and give producers the complete picture of their herd. View their product line at 701x.com.

At the heart of the wearables category is the xTpro — a GPS smart ear tag that utilizes direct-to-satellite connectivity to deliver real-time data and alerts straight to a rancher’s phone, no matter where the herd is located. Equipped with a suite of onboard sensors, the xTpro enables 701x to provide producers with instant alerts for out-of-fence events, animal health changes, estrus detection, calving activity, and bull-not-mounting notifications — putting critical herd intelligence in the palm of a rancher’s hand around the clock.

Profitability Fueled by Heavy R&D Investment

701x has achieved its first profitable month — a significant milestone for a company that continues to direct the majority of its labor budget toward research and development. Current R&D priorities include completing a comprehensive overhaul of an acquired registry software platform and advancing innovation toward a full feedlot management system, both of which represent major near-term milestones for the company and its customers.

75% Reduction in Assembly Costs for the xTpro Tag

Through the integration of robotics and automation throughout its production line, 701x has reduced assembly costs for its signature xTpro smart ear tag by 75%. This manufacturing transformation is no accident: 701x Founder and CEO, Kevin Biffert, built Fargo Automation from the ground up as its sole owner, developing high-speed automation machinery for some of the largest pharmaceutical companies across the globe before selling the company to Körber Medipak in 2017. That deep expertise in precision manufacturing is now being applied directly to 701x’s production operations, allowing the company to achieve significant efficiencies of scale and deliver high-quality, low-cost products to the market at scale — an advantage that grows as production volumes increase.

World-Class Talent Joins for Global Expansion

To support its global ambitions, 701x has brought on world-class talent across key functions. The company is already live in Canada and is on track to launch in the following markets before the end of the year:

AustraliaNew ZealandMexicoUnited KingdomBrazil

This expansion positions 701x as a truly global platform for the beef cattle industry, bringing precision livestock technology to producers across four continents.

“701x was founded because the beef industry deserves better technology — not outdated or single function piecemeal tools, but a connected ecosystem designed specifically for cattle producers. 701x provides tools with the greatest ROI by targeting ranchers true pain points – fertility and health metrics for their cattle. Closing an oversubscribed round funded by our neighbors, our community, and our own customers is the kind of validation that means the most to us. This is just the beginning.”
— Kevin Biffert, CEO, 701x

About 701x

Founded in Fargo, North Dakota, 701x is building a complete technology ecosystem exclusively for the beef cattle industry. The 701x platform brings together on-ranch management software, breed association tools, smart wearables, DNA solutions, and accessory products into a single connected system for cattle producers. With strong adoption across the United States and active operations in Canada, 701x is expanding globally to bring precision livestock technology to beef producers worldwide. Learn more at www.701x.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/701x-closes-oversubscribed-series-b-and-launches-global-expansion-302792092.html

SOURCE 701x, Inc.

Continue Reading

Technology

The Inner Circle acknowledges Cha-Mei Tang as a Pinnacle Professional Member Inner Circle of Excellence

Published

on

By

POTOMAC, Md., June 4, 2026 /PRNewswire/ — Prominently featured in The Inner Circle, Cha-Mei Tang is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for her contributions to Pioneering Cancer Diagnostics and Cancer Screening by a blood test based on a type of revolutionary tumor associated cell. This laboratory procedure is performed primarily by the Creatv Bio Division of Creatv MicroTech.

Dr. Cha-Mei Tang, a well-known innovator in cancer diagnostics and cancer screening, has dedicated the past 15 years toward advancing technologies and clinical data that transform the landscape of cancer care. Dr. Tang has spearheaded groundbreaking research, including the development of a revolutionary LifeTracDx® blood test for cancer diagnostics. As a microfabrication company in 2010, the company developed a microfilter with the goal to capture circulating tumor cells (CTCs) from the blood of cancer patients. From the first patient sample, the microfilter captured a lot of giant cells that were previously ignored by cancer researchers, Dr. Tang and her colleague, Daniel L. Adams, now the Chief Scientific Officer, lead the systematical analysis of those cells and found that they are macrophages that engulf tumor cells. Dr. Tang’s team called them cancer associated macrophage-like cells (CAMLs).

Creatv showed that CAMLs are the most useful biomarkers available for cancer screening and cancer diagnostics. CAMLs are found in all types of cancer and in all stages, but not in healthy individuals. The number and biological features of the CAMLs can provide valuable information (https://creatvbio.com).

Dr. Tang’s current focus is on cancer diagnostics. LifeTracDx® blood test is applicable to all types of cancer. The clinical data suggests that LifeTracDx® can (1) provide real time prognosis at any time, (2) predict treatment response in ~30 days after first dose of treatment, (3) provide companion diagnostics – not requiring tissue, (4) monitor biomarker expression or change of biomarker – example: change of PD-L1 expression on the tumor. PD-L1 expression predicts treatment response of immunotherapy, (5) detect cancer recurrence and minimal residual disease (MRD), and (6) deliver high quality tumor DNA for sequencing. LifeTracDx® blood tests provide physicians and patients with critical insights into cancer diagnostics, saving and improving lives.

Dr. Tang’s academic achievements stem from her earning multiple degrees from the Massachusetts Institute of Technology (MIT), including a Doctor of Science, Master of Science, and Bachelor of Science, all in Electrical Engineering and Computer Science. After graduation, she performed research on relativistic electron beams and free electron lasers as Head of the Radiation and Accelerator Physics Section at the U.S. Naval Research Laboratory (NRL). She also took a sabbatical at the National Institute of Standards and Technology (NIST) before founding Creatv MicroTech. Her interdisciplinary expertise bridges physics, engineering, microfabrication and biological science, driving the cutting-edge innovations that define her career.

Recognized for her many contributions, Dr. Tang has received numerous prestigious awards. These include being named a Fellow of the American Physical Society in 1990, receiving the WISE Award for Science for the Most Outstanding Woman Scientist in the Federal Government in 1992, and being honored as a Senior Member of the IEEE in 1995. Her innovative work also earned the R&D 100 Award from R&D Magazine in 2006, and her company, Creatv MicroTech, was named Bioscience Company of the Year in Montgomery County Maryland in 2013. Dr. Tang was inducted into Marquis Who’s Who in 2024.

Dr. Tang is an active member of several professional organizations, including the American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), American Physical Society (APS), and IEEE. She and her colleagues at Creatv regularly present their research at conferences and publish findings that advance the field of cancer diagnostics and cancer screening.

Creatv recently obtained CLIA approval, enabling the performance of some of the LifeTracDx® blood tests at its CLIA-certified laboratory at Monmouth Junction, NJ. The initial focus is on collaboration with cancer drug companies to help them understand the performance of their drugs. Creatv is also starting to apply for FDA approvals for various cancer diagnostics applications. Her dedication to innovation and saving lives underscores her vision of a future where cancer is detected earlier, when it matters most, and can be treated more effectively.

Contact: Katherine Green, 516-825-5634, editorialteam@continentalwhoswho.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-cha-mei-tang-as-a-pinnacle-professional-member-inner-circle-of-excellence-302791986.html

SOURCE The Inner Circle

Continue Reading

Trending